Cargando…

Correction: Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309585/ https://www.ncbi.nlm.nih.gov/pubmed/25629614 http://dx.doi.org/10.1371/journal.pmed.1001787

Ejemplares similares

Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts
por: Tammemägi, Martin C., et al.
Publicado: (2014)

OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations
por: Pan, Zoucheng, et al.
Publicado: (2023)

The performance of NLST screening criteria in Asian lung cancer patients
por: Kumar, Vivek, et al.
Publicado: (2015)

Lung cancer risk score for ever and never smokers in China
por: Ma, Zhimin, et al.
Publicado: (2023)

Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST)
por: Kramer, Barnett S, et al.
Publicado: (2011)

Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria
por: Fu, Marcela, et al.
Publicado: (2018)

The greater use of flavoured snus among ever-smokers versus never-smokers in Norway
por: Vedoy, Tord Finne, et al.
Publicado: (2020)

Early Detection of Lung Cancer in the NLST Dataset
por: Mukherjee, Pritam, et al.
Publicado: (2023)

Time to First Morning Cigarette and Risk of Chronic Obstructive Pulmonary Disease: Smokers in the PLCO Cancer Screening Trial
por: Guertin, Kristin A., et al.
Publicado: (2015)

Similar Squamous Cell Carcinoma Epithelium microRNA Expression in Never Smokers and Ever Smokers
por: Kolokythas, Antonia, et al.
Publicado: (2015)

Detection method has independent prognostic significance in the PLCO lung screening trial
por: Long, James P., et al.
Publicado: (2023)

Biomarkers of lung cancer for screening and in never-smokers—a narrative review
por: Stephens, Edward K. H., et al.
Publicado: (2023)

‘Reduced’ HUNT model outperforms NLST and NELSON study criteria in predicting lung cancer in the Danish screening trial
por: Røe, Oluf Dimitri, et al.
Publicado: (2019)

Author Correction: Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan
por: Wu, Xifeng, et al.
Publicado: (2020)

Low-dose CT lung cancer screening in never-smokers and smokers: results of an eight-year observational study
por: Kakinuma, Ryutaro, et al.
Publicado: (2020)

“To know or not to know…?” Push and pull in ever smokers lung screening uptake decision‐making intentions
por: Tonge, Janet E., et al.
Publicado: (2018)

Updated cost-effectiveness analysis of lung cancer screening for Australia, capturing differences in the health economic impact of NELSON and NLST outcomes
por: Behar Harpaz, Silvia, et al.
Publicado: (2022)

The impact of folate intake on the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort
por: Kawakita, Daisuke, et al.
Publicado: (2018)

Chronic airflow limitation and its relation to respiratory symptoms among ever-smokers and never-smokers: a cross-sectional study
por: Toren, Kjell, et al.
Publicado: (2020)

Genetic differences between smokers and never-smokers with lung cancer
por: Kuśnierczyk, Piotr
Publicado: (2023)

Weight Change and Incident Distal Colorectal Adenoma Risk in the PLCO Cancer Screening Trial
por: He, Shisi, et al.
Publicado: (2022)

Ever at the ready for events that never happen
por: Brosschot, Jos F.
Publicado: (2017)

Risk-based prediction model for selecting eligible population for lung cancer screening among ever smokers in Korea
por: Park, Boyoung, et al.
Publicado: (2021)

Genomic Aberrations in Lung Adenocarcinoma in Never Smokers
por: Job, Bastien, et al.
Publicado: (2010)

Molecular profile of lung cancer in never smokers
por: Subramanian, Janakiraman, et al.
Publicado: (2013)

Small-cell lung cancer in never-smokers
por: Torres-Durán, M., et al.
Publicado: (2021)

Lung cancer and obstructive lung disease in never smokers
por: Yoneyama, Remi, et al.
Publicado: (2020)

Evaluation of the accuracy of the PLCO(m2012) 6-year lung cancer risk prediction model among smokers in the CARTaGENE population-based cohort
por: Jantzen, Rodolphe, et al.
Publicado: (2023)

Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort
por: Lacey, James V, et al.
Publicado: (2009)

Distinct immune microenvironment of lung adenocarcinoma in never-smokers from smokers
por: Luo, Wenxin, et al.
Publicado: (2023)

Body mass index and mortality among blacks and whites in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
por: Xiao, Qian, et al.
Publicado: (2013)

Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort
por: Hashibe, Mia, et al.
Publicado: (2015)

Intratumoral Heterogeneity and Immune Modulation in Lung Adenocarcinoma in Female Smokers and Never Smokers
por: Trefzer, Timo B., et al.
Publicado: (2022)

287 Genomic and Immunologic Characterization of Lung Adenocarcinoma in Never Smokers vs. Smokers
por: Li, P. Jonathan, et al.
Publicado: (2023)

Lung Cancer Screening with Low-Dose CT in Female Never Smokers: Retrospective Cohort Study with Long-term National Data Follow-up
por: Kim, Hyae Young, et al.
Publicado: (2018)

White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
por: Sturgeon, Susan R., et al.
Publicado: (2017)

DNA methylation is associated with lung function in never smokers
por: de Vries, Maaike, et al.
Publicado: (2019)

Is lung cancer in never smokers still an unknown disease?
por: Candal-Pedreira, Cristina, et al.
Publicado: (2022)

Prospective study of the relationship between coffee and tea with colorectal cancer risk: The PLCO Cancer Screening Trial
por: Dominianni, C, et al.
Publicado: (2013)

Using machine learning algorithms to review computed tomography scans and assess risk for cardiovascular disease: Retrospective analysis from the National Lung Screening Trial (NLST)
por: Stemmer, Amos, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ff6jgcaj1qleqt53qpbmshr6n0